Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
102 participants
INTERVENTIONAL
2019-12-13
2022-05-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The names of the study interventions involved in this study may include:
* Questionnaires
* Video
* Phone Interview
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Using Videos in Advance Care Planning for Patients With Advanced Cancer
NCT01241929
Advance Care Planning: Promoting Effective and Aligned Communication in the Elderly
NCT03609177
Using Video Images to Improve Advance Care Planning in Patients With Cancer
NCT00970125
FAmily CEntered (FACE) Advance Care Planning for Teens With Cancer
NCT01670461
A ProspectiveTrial Using Video Images in Advance Care Planning in Hospitalized Seriously Ill Patients With Advanced Cancer
NCT01527331
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
\- Patients and their caregivers will be randomized into the same group; either ACP video decision aid intervention or usual care.
* Patients' and caregivers' knowledge, preferences (goals of care, CPR, ventilation), and decisional conflict be assessed before and after the ACP video decision aid intervention or usual care.
* Participants will be in this research study for up to 3 months with only 2 study visits.
* It is expected that about 100 people (50 patients and 50 caregivers) will take part in this research study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ACP video decision aid
The research study procedures include: screening for eligibility and study interventions including questionnaires and follow up visits.
* In-person interview where the patient and caregiver together will randomized to either the video aid intervention or standard care
* 10 minute video decision aid: describing the goals-of-care options .
* Follow telephone interview at 3 months
ACP video decision aid
10 minute video decision aid describing the goals-of-care options
Standard Care
The research study procedures include: screening for eligibility and study interventions including questionnaires and follow up visits.
* In-person interview where the patient and caregiver together will randomized to either the video aid intervention or standard care
* Receive the verbal description of the three types of care
* Follow telephone interview at 3 months
Usual Care-
Verbal description of the three types of care
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ACP video decision aid
10 minute video decision aid describing the goals-of-care options
Usual Care-
Verbal description of the three types of care
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Patient Eligibility criteria will include patients who are:
i) Diagnosed with advanced cancer (i.e., initial first-line therapy is unsuccessful, marked by progression or relapsed disease) ii) Aged between 18-39, which is the legal age for completing an ACP document (e.g., POLST/MOLST); iii) Speak English; and iv) Have a caregiver or identified surrogate decision maker who is able to participate.
v) Treated at Dana-Farber Cancer Institute or Massachusetts General Hospital
Exclusion Criteria
ii) Visually impaired (note, hearing impaired is not an exclusion as the video is closed captioned); iii) Psychological state not appropriate for ACP discussions as determined by the primary oncologist; and, iv) Unable to participate in ACP discussions due to mental incapacity as determined by the Short Portable Mental Status Questionnaire
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dana-Farber Cancer Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jennifer Snaman, MD, MS
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jennifer Snaman, MD, MS
Role: PRINCIPAL_INVESTIGATOR
Dana-Farber Cancer Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Boston Children's Hospital
Boston, Massachusetts, United States
Brigham and Women's Hospital
Boston, Massachusetts, United States
Dana Farber Cancer Institute
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Snaman JM, Feifer D, Helton G, Chang Y, El-Jawahri A, Volandes AE, Wolfe J. A Pilot Randomized Trial of an Advance Care Planning Video Decision Support Tool for Adolescents and Young Adults With Advanced Cancer. J Natl Compr Canc Netw. 2023 Jul;21(7):715-723.e17. doi: 10.6004/jnccn.2023.7021.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
19-409
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.